Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases... Show more
WINT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 49 cases where WINT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator entered the oversold zone -- be on the watch for WINT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WINT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for WINT entered a downward trend on August 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
a manufacturer of pharmaceuticals
Industry Biotechnology